Who can use Endobloc(Ambrisentan)?

Endobloc (Ambrisentan) is indicated for adult patients with pulmonary arterial hypertension (WHO Group 1) to improve exercise capacity and delay clinical worsening, including use in combination with tadalafil.

Indicated Patient Population

Endobloc is approved for adults with PAH (WHO Group 1), including idiopathic, heritable, or connective tissue disease-associated etiologies. It is used as monotherapy or combined with tadalafil to reduce disease progression and hospitalization risks. Efficacy was established in patients predominantly in WHO Functional Class II–III.

Related Columns

Ambrisentan(Endobloc)

Ambrisentan Tablets, available in 5 mg and 10 mg dosages, are indicated for the...

WeChat Scan
Free Inquiry

What Are the Indications of Ambrisentan?

Ambrisentan is an effective therapeutic drug for pulmonary arterial hypertension (PAH). However, during its use, patients must strictly follow the doctor’s guidance and pay attention to the relevant c...

Ambrisentan(Endobloc):Clinical Uses, Recommended Dosage, Treatment Effect

With its unique pharmacological effects, Ambrisentan has brought good news to many patients, helping them alleviate the pain caused by diseases. Just like any other medication, the use of Ambrisentan ...

What is Ambrisentan?

Ambrisentan is a drug used to treat pulmonary hypertension. It is an endothelin receptor antagonist that reduces pulmonary artery pressure by dilating blood vessels, thereby reducing the burden o...

Is Ambrisentan suitable for the elderly?

As a drug used to treat pulmonary hypertension, the applicability of Ambrisentan in different populations needs to be evaluated according to specific circumstances. For elderly patients, medicati...